Adverse events from cough and cold medications after a market withdrawal of products labeled for infants

Pediatrics

Volumn 126, Issue 6, 2010, Pages 1100-1107

  Shehab, Nadine ^a   Schaefer, Melissa K ^a   Kegler, Scott R ^b   Budnitz, Daniel S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

Author keywords

Adverse events; Antitussive agents; Drug packaging; Drug safety; Expectorants; Medication errors; Nasal decongestants; Nonprescription drugs; Poisoning; Product withdrawals

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; DECONGESTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RESPIRATORY TRACT AGENT; SALICYLIC ACID;

ARTICLE; CHILD; DRUG ERUPTION; DRUG INTOXICATION; DRUG LABELING; DRUG MARKETING; FEMALE; GROUPS BY AGE; HUMAN; HYPERACTIVITY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; UNITED STATES; UNSPECIFIED SIDE EFFECT; UNSTEADINESS; URTICARIA;

ANTITUSSIVE AGENTS; CHILD; CHILD, PRESCHOOL; COMMON COLD; COUGH; DRUG LABELING; DRUG TOXICITY; EXPECTORANTS; FEMALE; HUMANS; MALE; NASAL DECONGESTANTS; NONPRESCRIPTION DRUGS; PRODUCT RECALLS AND WITHDRAWALS;

EID: 78649662149     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1839     Document Type: Article

References (31)

1. Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over-the-counter cough and cold medications. Pediatrics. 2001;108(3). Available at: www.pediatrics.org/cgi/content/full/108/3/e52
2. Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar: pediatric cough and cold medications. N Engl J Med. 2007;357(23):2321-2324
3. US Food and Drug Administration. Nonprescription Drug Advisory Committee Meeting: cold, cough, allergy, bronchodilator, antiasthmatic drug products for over-the-counter human use, October 18 and 19, 2007. Available at: www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4323b1-02-FDA.pdf. Accessed May 3, 2010
4. Dolansky G, Rieder M. What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age? Paediatr Child Health. 2008;13(2):125-127
5. Vassilev ZP, Kabadi S, Villa R. Safety and efficacy of over-the-counter cough and cold medicines for use in children. Expert Opin Drug Saf. 2010;9(2):233-242
6. Centers for Disease Control and Prevention. Infant deaths associated with cough and cold medications: two states. MMWR Morb Mortal Wkly Rep. 2007;56(1):1-4
7. Rimsza ME, Newberry S. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics. 2008;122(2). Available at: www.pediatrics.org/cgi/content/full/122/2/e318
8. Pitetti RD, Whitman E, Zaylor A. Accidental and nonaccidental poisonings as a cause of apparent life-threatening events in infants. Pediatrics. 2008;122(2). Available at: www.pediatrics.org/cgi/content/full/122/2/e359
9. Dart RC, Paul IM, Bond GR, et al. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med. 2009;53(4):411-417
10. Consumer Healthcare Products Association. Makers of OTC cough and cold medicines announce voluntary withdrawal of oral infant medicines, October 11, 2007. Available at: www.chpa-info.org/10-11-07-OralInfantMedicines.aspx. Accessed May 3, 2010
11. US Food and Drug Administration. News & Events. FDA Releases Recommendations Regarding Use of Over-the-Counter Cough and Cold Products. Products should not be used in children under 2 years of age; evaluation continues in older populations. Available at: www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2008/ucm116839.htm. Accessed May 3, 2010
12. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA. 2006;296(15):1858-1866
13. Jhung MA, Budnitz DS, Mendelsohn AB, et al. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES). Med Care. 2007;45(10 suppl 2):S96-S102
14. Kish L. Survey Sampling. New York, NY: Wiley Inter-Science; 1995
15. Klein-Schwartz W, Sorkin JD, Doyon S. Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers. Pharmacoepidmiol Drug Saf. 2010;19(8):819-824
16. NPR; Kaiser Family Foundation; Harvard School of Public Health. Children's OTC cold medicines: the public, and parents, weigh in, December 2007. Available at: www.kff.org/kaiserpolls/upload/7726.pdf. Accessed May 3, 2010
17. Lokker N, Sanders L, Perrin EM, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464-1471
18. Yaghmai BF, Cordts C, Ahlers-Schmidt CR, Issa BA, Warren RC. One community's perspective on the withdrawal of cough and cold medications for infants and young children. Clin Pediatr (Phila). 2010;49(4):310-315
19. Garbutt JM, Sterkel R, Banister C, Walber T, Strunk RC. Physician and parent response to the FDA advisory about use of over-the-counter cough and cold medications. Acad Pediatr. 2010;10(1):64-69
20. Hanoch Y, Gummerum M, Miron-Shatz T, Himmelstein M. Parents' decision following the Food and Drug Administration recommendation: the case of over-the-counter cough and cold medication. Child Care Health Dev. 2010;36(6):795-804
21. Consumer Healthcare Products Association. Statement from CHPA on the voluntary label updates to oral OTC children's cough and cold medicines, October 7, 2008. Available at: www.chpa-info.org/10-07-08-PedCC.aspx. Accessed May 3, 2010
22. US Food and Drug Administration. FDA statement following CHPA's announcement on nonprescription over-the-counter cough and cold medicines in children. Available at: www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ 2008/ucm116964.htm. Accessed May 3, 2010
23. Kaushal R, Goldmann DA, Keohane CA, et al. Adverse drug events in pediatric outpatients. Ambul Pediatr. 2007;7(5):383-389
24. Shah K, Barker KA. Out-of-hospital medication errors: a 6-year analysis of the national poison data system. Pharmacoepidmiol Drug Saf. 2009;18(11):1080-1085
25. Yin HS, Mendelsohn AL, Wolf MS, et al. Parents' medication administration errors: role of dosing instruments and health literacy. Arch Pediatr Adolesc Med. 2010;164(2):181-186
26. Madlon-Kay DJ, Mosch FS. Liquid medication dosing errors. J Fam Pract. 2000;49(8):741-744
27. Litovitz T. Implication of dispensing cups in dosing errors and pediatric poisonings: a report from the American Association of Poison Control Centers. Ann Pharmacother. 1992;26(7-8):917-918
28. Sobhani P, Christopherson J, Ambrose PJ, Corelli RL. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe. Ann Pharmacother. 2008;42(1):46-52
29. Consumer Healthcare Products Association. Volumetric measures for dosing of over-thecounter oral liquid drug products for children ≤12 years of age. Available at: www.chpa-info.org/scienceregulatory/Voluntary-Codes. aspx#volumetricmeasure. Accessed May 3, 2010
30. US Food and Drug Administration. Guidance for industry: dosage delivery devices for OTC liquid drug products. Available at: www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM188992.pdf. Accessed May 3, 2010
31. Schaefer MK, Shehab N, Cohen AL, Budnitz DS. Adverse events from cough and cold medications in children. Pediatrics. 2008;121(4):783-787